Clinical Trial Update: Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on androgen therapy for breast cancer patients experiencing aromatase inhibitor-induced side-effects, such as osteoporosis; no res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Osteoporosis

Drugs mentioned

• Androgen therapy (androgen)

Snippet

Sponsor: Havah Therapeutics Pty Ltd | Conditions: Breast Cancer, Arthralgia | Phase 2 | Status: UNKNOWN